摘要
[背景]观察孟鲁司特钠(顺尔宁)治疗婴幼儿哮喘的疗效.[病理报告]将60例轻中度婴幼儿哮喘患儿随机分为2个组,分别给予口服孟鲁司特钠及吸入布地奈德,随访3个月,观察疗效.结果显示,两组患儿的喘息消失时间和复发率比较均无明显差异.[讨论]孟鲁司特钠可替代激素类药物,用于6个月以上的哮喘患儿,尤其是吸入治疗效果不佳的轻中度哮喘患儿.
BACKGROUND To observe the curative effects of the montelukast for the infantile asthma. CASE REPORTS 60 infants with light and medium asthma were randomly assigned to two groups of 30 children each. Experimental group was treated with the montelukast by oral and control group were inhaled with the budesonide. Curative effects were evaluated after following up for 3 months. There were no statistically significant differences in extinction time of gasping and recurrence rate. DISCCUSION The montelukast could be used to infant with over 6 months of asthma,especially for the light and medium asthma that the treating effects of inhalation were not so good.
出处
《延边大学医学学报》
CAS
2009年第4期281-282,共2页
Journal of Medical Science Yanbian University
关键词
抗哮喘药
儿童
学龄前
治疗结果
anti-asthmatic agents
child
preschool
treatment outcome
